Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
about
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)Antimicrobial resistance and management of invasive Salmonella diseaseEpidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella InfectionsAntimicrobial resistance, virulence profiles and molecular subtypes of Salmonella enterica serovars Typhi and Paratyphi A blood isolates from Kolkata, India during 2009-2013Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones.Pediatricians' perceptions of vaccine effectiveness and safety are significant predictors of vaccine administration in India.The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapyInduction of resistant mutants of Salmonella enterica serotype Typhi under ciprofloxacin selective pressurePlasmid-mediated resistance to cephalosporins in Salmonella enterica serovar TyphiAntibacterial resistance in sub-Saharan Africa: an underestimated emergency.Human genome-wide RNAi screen for host factors that modulate intracellular Salmonella growth.Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolonesResistance pattern of ciprofloxacin against different pathogens.Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi ACiprofloxacin-resistant Salmonella enterica Serotype Typhi, United States, 1999-2008.Molecular typing and resistance analysis of travel-associated Salmonella enterica serotype TyphiHuman Genome-Wide RNAi Screen for Host Factors That Facilitate Salmonella Invasion Reveals a Role for Potassium Secretion in Promoting Internalization.Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium.Lack of efflux mediated quinolone resistance in Salmonella enterica serovars Typhi and Paratyphi A.Quinolone and cephalosporin resistance in enteric Fever.How multidrug resistance in typhoid fever affects treatment options.Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.Enteric fever in Cambodian children is dominated by multidrug-resistant H58 Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin.The decline of typhoid and the rise of non-typhoid salmonellae and fungal infections in a changing HIV landscape: bloodstream infection trends over 15 years in southern Vietnam.Enteric fever imported to the Czech Republic: epidemiology, clinical characteristics and antimicrobial susceptibility.Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993-2003.Recurrent paratyphoid fever A co-infected with hepatitis A reactivated chronic hepatitis B.Bacteraemia with pleural effusions complicating typhoid fever caused by high-level ciprofloxacin-resistant Salmonella enterica serotype Typhi.Ciprofloxacin-resistant Salmonella enterica serovar typhi from Kuwait with novel mutations in gyrA and parC genes.Molecular analysis of high-level ciprofloxacin resistance in Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region?Molecular Characterization of Intermediate Susceptible Typhoidal Salmonella to Ciprofloxacin, and its Impact.Attenuation of in vitro host-pathogen interactions in quinolone-resistant Salmonella Typhi mutants.Multiple-locus variable number of tandem repeats analysis of Salmonella enterica serotype paratyphi A from Yuxi and comparison with isolates from the Chinese Medical Culture Collection Center.Emergence of fluoroquinolone resistance in Salmonella enterica serovar Typhi in Andaman and Nicobar Islands, IndiaA multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A.Pitfalls of interpreting ciprofloxacin minimum inhibitory concentrations in Salmonella enterica serovar Typhi.Salmonella enterica serovar Typhi in Japan, 2001-2006: emergence of high-level fluoroquinolone-resistant strains.Detection of blaCTX-M Extended Spectrum Beta-lactamase Producing Salmonella enterica Serotype Typhi in a Tertiary Care Centre.Characterization of antimicrobial resistance markers & their stability in Salmonella enterica serovar Typhi.Detection of mutations in gyrB using denaturing high performance liquid chromatography (DHPLC) among Salmonella enterica serovar Typhi and Paratyphi A.
P2860
Q24236124-58BE1D86-3BDE-4F40-831C-0CCC95920753Q28080658-9100A9DD-493E-44B3-9EF6-36ED02A6CB79Q28084595-A9DAB0B7-A192-472D-9459-FD1803B50C2AQ28541644-6970C3BE-FE46-4E1C-85D3-7B7538B25505Q33301096-68DBB921-69CC-433F-B7D5-607705B1E69DQ33910984-FFB4B11E-2D5D-4327-AFC3-EB0F43B7D563Q33945463-5CFCAA8D-2090-4981-BB37-8A4E7580C057Q34073057-84B6B56F-02CD-4BD9-8379-BA6B6762E6BAQ34108740-4F5077C4-FB34-4843-9CB3-C6607B887E31Q34156590-67A9FEF2-BB27-4954-B658-8AB522BE6229Q34305317-661A49B6-8C7A-47E9-8864-E7327399A057Q34309550-C14EB9FE-185D-4276-972B-30554AC7B14CQ35323705-70AE3EDD-871F-4231-A756-BF342BEE67B3Q35385211-80A22676-2DFD-4EA3-9BC8-91E1DDCB4207Q35997526-D2026286-0D1B-44E3-82E4-A2AE0F3DF1DDQ36171379-E42D421E-D742-437A-994B-7420E60177C5Q36202533-95B13BCA-38DD-45EC-BA80-36442F8E40F1Q36757682-05268279-1360-4601-9303-CCB980A8E201Q37516255-2533781D-EA0C-4757-931C-5F3E09CB41EBQ37798457-B683F923-510B-4BF0-BDC0-8048FB47D548Q38234712-F7E784E1-3418-485A-9599-3C6826A9627BQ38952157-F666FDC0-AD8D-4FAE-B33B-B74B14C27A0BQ38993278-10519637-A839-4262-84DA-7226593A89A2Q39301426-F52E89B5-0721-4537-B525-DB377C6A7194Q39534480-EE87CB2A-F5E5-4F8C-B02A-D2102878F285Q39822210-43A37644-5570-47DD-B0DF-9543B9DBACCEQ40205278-2664F04E-F2E2-41C9-A866-849544D61175Q40348964-CFC3917A-AFB8-4063-A9F8-A75E603B11BBQ40406142-C2DBEE3A-4D31-48A6-8DAC-A948DA11E881Q40412595-CEE89289-BBD6-47E5-BE36-26521F46CADCQ40764604-1AEE006B-4745-4DED-9559-385AE4A5296DQ40962273-84D52712-467F-4EB6-8711-DDB7C18D8BF1Q41088420-7B1F653C-3683-4583-A71E-E973E7E7300CQ42540420-055917B4-C348-4D33-9D60-993DF56449FAQ42593521-A3B5F3AC-D077-44E6-86E4-4885765C7142Q43246706-08097BD1-B2B7-42C3-B4F4-8D7BF29F0419Q44100702-C3A6A542-5F5A-4C3C-96AB-F2A8AF642A2EQ46247544-19C32185-0EE5-410F-A7E1-36E7374C5C43Q46248055-8694CB45-FA84-42BA-9CF4-8B4D024C2624Q47815057-97B3E60D-6805-4694-BE89-19BD4BF152CE
P2860
Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Molecular characterization of ...... ausing enteric fever in India.
@en
type
label
Molecular characterization of ...... ausing enteric fever in India.
@en
prefLabel
Molecular characterization of ...... ausing enteric fever in India.
@en
P2093
P356
P1476
Molecular characterization of ...... causing enteric fever in India
@en
P2093
Aggarwal P
Cappuccinelli P
P304
P356
10.1093/JAC/DKL391
P407
P577
2006-10-28T00:00:00Z